- Home
- KURA vs USAS Comparison
KURA vs USAS Comparison
Compare KURA & USAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KURA
- USAS
- Stock Information
- Founded
- KURA 2014
- USAS 1998
- Country
- KURA United States
- USAS Canada
- Employees
- KURA N/A
- USAS N/A
- Industry
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- USAS Metal Mining
- Sector
- KURA Health Care
- USAS Basic Materials
- Exchange
- KURA Nasdaq
- USAS Nasdaq
- Market Cap
- KURA 1.0B
- USAS 1.1B
- IPO Year
- KURA N/A
- USAS N/A
- Fundamental
- Price
- KURA $12.08
- USAS $4.27
- Analyst Decision
- KURA Buy
- USAS Strong Buy
- Analyst Count
- KURA 11
- USAS 2
- Target Price
- KURA $25.00
- USAS $4.08
- AVG Volume (30 Days)
- KURA 2.2M
- USAS 3.1M
- Earning Date
- KURA 11-04-2025
- USAS 11-10-2025
- Dividend Yield
- KURA N/A
- USAS N/A
- EPS Growth
- KURA N/A
- USAS N/A
- EPS
- KURA N/A
- USAS N/A
- Revenue
- KURA $104,029,000.00
- USAS $104,867,000.00
- Revenue This Year
- KURA $68.63
- USAS $26.26
- Revenue Next Year
- KURA $141.59
- USAS $67.48
- P/E Ratio
- KURA N/A
- USAS N/A
- Revenue Growth
- KURA N/A
- USAS N/A
- 52 Week Low
- KURA $5.41
- USAS $0.87
- 52 Week High
- KURA $12.49
- USAS $5.12
- Technical
- Relative Strength Index (RSI)
- KURA 66.94
- USAS 57.97
- Support Level
- KURA $10.86
- USAS $3.52
- Resistance Level
- KURA $11.88
- USAS $4.04
- Average True Range (ATR)
- KURA 0.88
- USAS 0.29
- MACD
- KURA 0.08
- USAS 0.00
- Stochastic Oscillator
- KURA 85.86
- USAS 76.92
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
About USAS Americas Gold and Silver Corporation no par value
Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.